Innate Pharma to participate in the 2025 Stifel Virtual Targeted Oncology Forum

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team will present and host 1x1 meetings at the Stifel 2025 Virtual Targeted Oncology Forum being held on April 8 – 9, 2025.

The executive team will participate in a fireside chat scheduled on Wednesday, April 9, 2025, from 12:30 - 12:55 p.m. ET.

A live webcast and a replay of the presentation will be available on the Events page in the Investors section of Innate Pharma website.